Immunochemotherapy
-
Addition of Rituximab Significantly Improves Outcomes in Patients with Diffuse Large B-cell Lymphoma – a Single-center, Retrospective Study
David Belada, Lukáš Smolej, Monika Hrudková, Pavla Štěpánková, Alice Sýkorová, Pavel Žák, Jiří Bukač, Jaroslav Malý
2007, Vol. 50, Issue 2, pp. 113-118
